Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Charge Carrier Lipid on Skin Penetration, Retention, and Hair Growth of Topically Applied Finasteride-Containing Liposomes

  • Received : 2010.11.16
  • Accepted : 2011.03.10
  • Published : 2011.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to investigate the effect of charge carrier lipid on the skin penetration, retention, and hair growth of topically applied finasteride-containing liposomes. Finasteride-containing liposomes were prepared by traditional thin film hydration method using Phospholipon$^{(R)}$ 85 G and cholesterol with or without charge carrier lipid (1,2 dimyristoyl-sn-glycero-3-phosphate or 1,2-dioleoyl-trimethylammonium-propane for anionic and cationic charge, respectively). Freshly prepared finasteride-containing liposome suspension was applied on the hairless mouse skin, and skin penetration and retention were measured using Keshary-Chien diffusion cell. Non-liposomal formulation (ethanol 10% solution containing 0.5 mg/ml of FNS) was also used as a control. The amount of finasteride in the diffusion cell and mouse skin was measured by HPLC. The hair growth was evaluated using depilated male C57BL/6N mice. Mean particle size of all finasteride-containing liposomes was less than a micron, and polydispersity index revealed size homogeneity. Skin penetration and retention studies showed that significantly less amount of finasteride was penetrated when applied as anionic liposome while more amount of the drug was retained. Specifically, in liposome prepared with 10% anionic charge carrier lipid, penetration was 12.99 ${\mu}g/cm^2$ while retention was 79.23 ${\mu}g/cm^2$ after 24 h of application. In hair growth study, finasteride-containing anionic liposomes showed moderate efficacy, but the efficacy was not found when applied as cationic liposomes. In conclusion, topical application of finasteride using anionic liposome formulation appears to be useful option for the treatment of androgenetic alopecia to avoid systemic side effects of the drug.

Keywords

References

  1. Allen, T. M., Austin, G. A., Chonn, A., Lin, L. and Lee, K. C. (1991) Uptake of liposomes by cultured mouse bone marrow macrophages: infl uence of liposome composition and size. Biochim. Biophys. Acta. 1061, 56-64. https://doi.org/10.1016/0005-2736(91)90268-D
  2. Balakrishnan, P., Shanmugam, S., Lee, W. S., Lee, W. M., Kim, J. O., Oh, D. H., Kim, D. D., Kim, J. S., Yoo, B. K., Choi, H. G., Woo, J. S. and Yong, C. S. (2010) Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int. J. Pharm. 377, 1-8.
  3. Biruss, B., Dietl, R. and Valenta, C. (2007) The infl uence of selected steroid hormones on the physicochemical behavior of DPPC liposomes. Chem. Phys. Lipids. 148, 84-90. https://doi.org/10.1016/j.chemphyslip.2007.04.009
  4. Biruss, B. and Valenta, C. (2006) Skin permeation of different steroid hormones from polymeric coated liposomal formulations. Eur. J. Pharm. Biopharm. 62, 210-219. https://doi.org/10.1016/j.ejpb.2005.08.004
  5. Burnette, R. R. and Ongpipattanakul, B. (1987) Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76, 765-773. https://doi.org/10.1002/jps.2600761003
  6. Chen, C. H., Sheu, M. T., Wu, A. B., Lin, K. P. and Ho, H .O. (2005) Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model. Int. J. Pharm. 306, 91-98. https://doi.org/10.1016/j.ijpharm.2005.09.005
  7. Fazekas, A. G. and Sandor, T. (1972) Metabolism of androgens by isolated human hair follicles. J. Steroid Biochem. 3, 485-491. https://doi.org/10.1016/0022-4731(72)90094-5
  8. Grit, M., Zuidam, N. J., Underberg, W. J. and Crommelin, D. J. (1993) Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics. J. Pharm. Pharmacol. 45, 490-495. https://doi.org/10.1111/j.2042-7158.1993.tb05585.x
  9. Hoffman, R. and Happle, R. (2000) Current understanding of androgenetic alopecia. Part II: Clinical aspects and treatment. Eur. J. Dermatol. 10, 410-417.
  10. Kirjavainen, M., Urtti, A., Jaaskelainen, I., Suhonen, T. M., Paronen, P., Valjakka-Koskela, R., Kiesvaara, J. and Monkkonen, J. (1996) Interaction of liposomes with human skin in vitro-the infl uence of lipid composition and structure. Biochim. Biophys. Acta. 1304, 179-189. https://doi.org/10.1016/S0005-2760(96)00126-9
  11. Kumar, R., Singh, B., Bakshi, G. and Katare, O. P. (2007) Development of liposomal systems of fi nasteride for topical applications: design, characterization, and in vitro evaluation. Pharm. Dev. Technol. 12, 591-601. https://doi.org/10.1080/10837450701481181
  12. Lebdai, S., Bigot, P. and Azzouzi, A. R. (2010) High-grade prostate cancer and finasteride. BJU Int. 105, 456-459. https://doi.org/10.1111/j.1464-410X.2009.09089.x
  13. Mella, J. M., Perret, M. C., Manzotti, M., Catalano, H. N. and Guyatt, G. (2010) Effi cacy and safety of fi nasteride therapy for androgenetic alopecia: a systematic review. Arch. Dermatol. 146, 1141-1150. https://doi.org/10.1001/archdermatol.2010.256
  14. Norwood, O. T. (1975) Male pattern baldness: classifi cation and incidence. South Med. J. 68, 1359-1365. https://doi.org/10.1097/00007611-197511000-00009
  15. Otberg, N., Finner, A. M. and Shapiro, J. (2007) Androgenetic alopecia. Endocrinol. Metab. Clin. North Am. 36, 379-398. https://doi.org/10.1016/j.ecl.2007.03.004
  16. Peters, D. H. and Sorkin, E. M. (1993) Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia. Drugs 46, 177-208.
  17. Piemi, M. P., Korner, D., Benita, S. and Marty, J. P. (1999) Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J. Control. Rel. 58, 177-187. https://doi.org/10.1016/S0168-3659(98)00156-4
  18. Rao, Y., Zheng, F., Zhang, X., Gao, J. and Liang, W. (2008) In vitro percutaneous permeation and skin accumulation of fi nasteride using vesicular ethosomal carriers. AAPS Pharm. Sci. Tech. 9, 860-865. https://doi.org/10.1208/s12249-008-9124-y
  19. Rittmaster, R. S., Lemay, A., Zwicker, H., Capizzi, T. P., Winch, S., Moore, E. and Gormley, G. J. (1992) Effect of fi nasteride, a 5 alphareductase inhibitor, on serum gonadotropins in normal men. J. Clin. Endocrinol. Metab. 75, 484-488. https://doi.org/10.1210/jc.75.2.484
  20. Rojanasakul, Y., Wang, L. Y., Bhat, M., Glover, D. D., Malanga, C. J. and Ma, J. K. (1992) The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm. Res. 9, 1029-1034. https://doi.org/10.1023/A:1015802427428
  21. Shanmugam, S., Baskaran, B., Nagayya-Sriraman, S., Yong, C. S., Choi, H. G., Woo, J. S. and Yoo, B. K. (2009) The effect of methylsulfonylmethane on hair growth promotion of magnesium ascorbyl phosphate for the treatment of alopecia. Biomol. Ther. 17, 241-248. https://doi.org/10.4062/biomolther.2009.17.3.241
  22. Tabbakhian, M., Tavakoli, N., Jaafari, M. R. and Daneshamouz, S. (2006) Enhancement of follicular delivery of fi nasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster fl ank and ear models. Int. J. Pharm. 323, 1-10. https://doi.org/10.1016/j.ijpharm.2006.05.041
  23. Takayasu, S., Wakimoto, H., Itami, S. and Sano, S. (1980) Activity of testosterone 5 alpha-reductase in various tissues of human skin. J. Invest. Dermatol. 74, 187-191. https://doi.org/10.1111/1523-1747.ep12541698
  24. Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., Carlin, S. M., Ryan, A., Szczepanek, C. M., Crowley, J. J. and Coltman, C. A. Jr. (2003) The infl uence of fi nasteride on the development of prostate cancer. N. Engl. J. Med. 349, 215-224. https://doi.org/10.1056/NEJMoa030660
  25. Thompson, I. M., Tangen, C. M., Parnes, H. L., Lippman, S. M. and Coltman, C. A. Jr. (2008) Does the level of prostate cancer risk affect cancer prevention with fi nasteride? Urology 71, 854-857. https://doi.org/10.1016/j.urology.2008.01.025

Cited by

  1. Design and In Vitro Evaluation of Finasteride-Loaded Liquid Crystalline Nanoparticles for Topical Delivery vol.14, pp.1, 2013, https://doi.org/10.1208/s12249-012-9888-y
  2. Liposomes in cosmeceutics vol.9, pp.4, 2012, https://doi.org/10.1517/17425247.2012.666968
  3. Evaluation of interstitial protein delivery in multicellular layers model vol.35, pp.3, 2012, https://doi.org/10.1007/s12272-012-0317-2
  4. Pitch-tunable pillar arrays for high-throughput culture and immunohistological analysis of tumor spheroids vol.8, pp.9, 2018, https://doi.org/10.1039/C7RA09090K
  5. Cationic Nanoliposomes Efficiently Delivering Phenylethyl Resorcinol Produce Enhanced Skin Lightening Effect vol.10, pp.4, 2011, https://doi.org/10.1142/s1793984420400097